Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Market Cap	3.74B -11.1%
Revenue (ttm)	2.22B +4.1%
Net Income	257.07M +110.5%
EPS	2.54 +110.0%
Shares Out	100.99M
PE Ratio	14.57
Forward PE	n/a
Dividend	1.60 (4.32%)
Ex-Dividend Date	Jul 3, 2025

Volume	47,657
Average Volume	101,338
Open	37.25
Previous Close	36.90
Day's Range	36.65 - 37.25
52-Week Range	30.00 - 43.95
Beta	0.23
RSI	55.74
Earnings Date	Mar 6, 2026

About Nang Kuang Pharmaceutical

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1963
• Employees: 552
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1752

Financial Performance

In 2024, Nang Kuang Pharmaceutical's revenue was 2.20 billion, an increase of 2.31% compared to the previous year's 2.15 billion. Earnings were 243.41 million, an increase of 22.68%.